0001855763-22-000019.txt : 20221018 0001855763-22-000019.hdr.sgml : 20221018 20221018182031 ACCESSION NUMBER: 0001855763-22-000019 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221012 FILED AS OF DATE: 20221018 DATE AS OF CHANGE: 20221018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUNKA CHRISTOPHER CENTRAL INDEX KEY: 0001103780 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 221316860 MAIL ADDRESS: STREET 1: 1924 BIRKDALE AVE CITY: KELOWNA STATE: A1 ZIP: V1P1R7 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2022-10-12 2022-10-13 0 0001348362 Lexaria Bioscience Corp. LEXX 0001103780 BUNKA CHRISTOPHER 1924 BIRKDALE AVE KELOWNA A1 V1P1R7 BRITISH COLUMBIA, CANADA 1 1 0 0 Chief Executive Officer common shares 273543 D common shares 215912 I Private Holding Company common shares 2022-10-12 4 P 0 21900 1.988 A 237812 I Private Holding Company common shares 2022-10-13 4 P 0 16600 2.1 A 254412 I Private Holding Company This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022. /Chris Bunka/ 2022-10-18